We demonstrated that the “leukocyte proliferation” pathway was significantly downregulated in C2 NK cells in B-ALL patients at diagnosis and that C2 NK cells overexpress KLF2. This evidence concerns the gene KLF2 and precursor B-cell acute lymphoblastic leukemia.